<p>Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy

Published:2019-09 Issue: Volume:Volume 11 Page:8657-8668
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Jiang Jinling,Ma Tao,Xi Wenqi,Yang Chen,Wu Junwei,Zhou Chenfei,Wang Nan,Zhu Zhenggang,Zhang Jun

Publisher

Informa UK Limited

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation on the cost–effectiveness of Cetuximab in treatment of colorectal cancer: a systematic review;Colorectal Cancer;2024-08-27

2. A nomogram combining NLR, PLR and SII to predict progression-free survival of cetuximab-based first-line therapy in patients with metastatic colorectal cancer;2023-01-23

3. The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy;International Journal of Clinical Oncology;2023-01-13

4. Clinicopathological and prognostic value of long non‑coding RNA CCAT1 expression in patients with digestive system cancer;Oncology Letters;2023-01-02

5. Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab;Therapeutic Advances in Medical Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP